Ebetrexat 20 mg/ml otopina za injekciju u napunjenoj štrcaljki
Name | Ebetrexat 20 mg/ml otopina za injekciju u napunjenoj štrcaljki |
---|---|
Marketing Authorisation Number | HR-H-123483008 |
Active Substance | dinatrijev metotreksat |
Composition | 1 ml otopine za injekciju sadrži 20 mg metotreksata u obliku dinatrijevog metotreksata |
Pharmaceutical Form | otopina za injekciju u napunjenoj štrcaljki |
Manufacturer | Ebewe Pharma GmbH Nfg. KG, Unterach am Attersee, Austrija Fareva Unterach GmbH, Unterach, Austrija |
Marketing Authorisation Holder | Sandoz d.o.o., Maksimirska 120, Zagreb, Hrvatska |
Marketing Authorisation Date | 05.02.2018 |
MA Period of Validity | unlimited |
Classification Number | UP/I-530-09/16-02/324 |
Registration Number | 381-12-01/30-18-08 |
Prescription | Medicinal product subject to medical prescription |
Type of prescription | ograničeni recept |
Distribution | Supply through pharmacies (community) |
Advertising to general public | not allowed |
ATC Code | L01BA01 |
Marketing status | stavljeno u promet |
Shortage status | nema nestašice |
SmPC | download |
PL | download |
Educational materials for patients / caregivers |
Vodič za bolesnike i njegovatelje, verzija 1, ožujak 2018 |
Packaging
Direct Healthcare Professional Communication
Name | Date | Download |
---|---|---|
Pismo zdravstvenim radnicima o preporukama za sprječavanje potencijalno fatalnih pogrešaka u doziranju metotreksata za liječenje upalnih bolesti | 02.12.2019 | Sandoz d.o.o., Pliva Hrvatska d.o.o., Actavis Group PTC ehf, Cipla Europe NV |